"It did not comply with the principle of equality because there were people who had potentially less access to medicines sent by the Remedy's Networks Program in the kits," says the latest report from the General Audit Office (AGN, for its acronym in Spanish) on the subject.

Since last week from the Auditor.info had published a note explaining the situation of R + R. But the report, which evaluated from 2011 to the first half of 2013, has a bigger picture.

The Watchdog analysis shows that "there were jurisdictions that received proportionately less kits" such as hotel guests, representing 37% of people with exclusive coverage of the country's citizens and receives between 23% and 25 % of medicines distributed in the audited period.

On the contrary, "Tucumán receives between 7.9% and 8.2% of its population kits when public coverage exclusively represents 3.7%." Something similar happens with Misiones which owns 3.3% of inhabitants in these conditions and gets between 4.8% and 5.3% of total the drugs delivered by R + R.

By relating the number of kits delivered to each province per year and those with unmet basic needs who reside in the same it observed that "in the City of Buenos Aires, for example, a kit was received for every 91 people in 2011 and one by every 142 in 2013." In San Luis, however, "the relationship was of a kit every 31 or 44 people per year."

It was from the Federal Health Plan 2011-2016 of the Ministry of Health that the implementation of integrated networks of health services for the development of provincial care models was proposed. Hence the R & R program aims to deliver medicines and the strengthening of judicial ties.

From the year 2011, after the signing of the framework agreements, the provinces began to receive funds. As of June 2013 they had been implemented U $ S 12.8 million U $ S 75.3 million available. The audit states that "considering that there were only six months of the original term of the loan is running low of 17% in this substantive axis".
As for Network coverage component the report notes that "only 18 of the 24 jurisdictions adhered to mid-2013, representing 75% of the total".

Regarding the Vademecum, the National Audit Office pointed out that "despite the intention of incorporating new drugs to treat high blood pressure and type 2 diabetes, no modifications to support the conclusion that adapted observed," even despite the recommendations of various associations of professionals and the Argentina Society of Hypertension.

On the general management of medicines, "inconsistencies in the amount of contract laboratories to provide the drugs as amounts paid, the amount of tendered drugs, received, envoys, discharged and end stock" were observed.

Finally, the report adopted in 2015 emphasizes that the program "does not have reliable information for making decisions about drugs" and one of the most resonant cases was that "according to records, the provinces received more medication then the Federal Government had sent, "something" factually impossible, according to the AGN.